| URL: | https://pk-db.com |
| Full name: | |
| Description: | An open issue in the field of pharmacokinetics is the reproducible and reusable storage of data from experimental and clinical studies, which is especially important for computational modeling. We present PK-DB an open database for pharmacokinetics information from clinical trials as well as pre-clinical research. The focus of PK-DB is to provide high-quality pharmacokinetics data enriched with the required meta-information for computational modeling and data integration. |
| Year founded: | 2021 |
| Last update: | |
| Version: | |
| Accessibility: |
Accessible
|
| Country/Region: | Germany |
| Data type: | |
| Data object: |
NA
|
| Database category: | |
| Major species: |
NA
|
| Keywords: |
| University/Institution: | Humboldt-University Berli |
| Address: | Institute for Theoretical Biology, Humboldt-University Berlin, Invalidenstraße 110, Berlin 10115, Germany. |
| City: | |
| Province/State: | Berlin |
| Country/Region: | Germany |
| Contact name (PI/Team): | Matthias K ̈onig |
| Contact email (PI/Helpdesk): | konigmatt@googlemail.com |
|
PK-DB: pharmacokinetics database for individualized and stratified computational modeling. [PMID: 33151297]
A multitude of pharmacokinetics studies have been published. However, due to the lack of an open database, pharmacokinetics data, as well as the corresponding meta-information, have been difficult to access. We present PK-DB (https://pk-db.com), an open database for pharmacokinetics information from clinical trials. PK-DB provides curated information on (i) characteristics of studied patient cohorts and subjects (e.g. age, bodyweight, smoking status, genetic variants); (ii) applied interventions (e.g. dosing, substance, route of application); (iii) pharmacokinetic parameters (e.g. clearance, half-life, area under the curve) and (iv) measured pharmacokinetic time-courses. Key features are the representation of experimental errors, the normalization of measurement units, annotation of information to biological ontologies, calculation of pharmacokinetic parameters from concentration-time profiles, a workflow for collaborative data curation, strong validation rules on the data, computational access via a REST API as well as human access via a web interface. PK-DB enables meta-analysis based on data from multiple studies and data integration with computational models. A special focus lies on meta-data relevant for individualized and stratified computational modeling with methods like physiologically based pharmacokinetic (PBPK), pharmacokinetic/pharmacodynamic (PK/PD), or population pharmacokinetic (pop PK) modeling. |